XBIOTECH INC. Stockholders' Equity Note, Subscriptions Receivable
XBIOTECH INC. (XBIT) had Stockholders' Equity Note, Subscriptions Receivable of $200.00 thousand as of 2018-12-31, per its 10-K filed 2020-03-16.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquityNoteSubscriptionsReceivable · last filed 2020-03-16
- 2018-12-31: Stockholders' Equity Note, Subscriptions Receivable $200.00K.
| Period end | Stockholders' Equity Note, Subscriptions Receivable |
|---|---|
| 2018-12-31 | $200.00K 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |